These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23223511)

  • 1. Genetic and epigenetic instability in human pluripotent stem cells.
    Nguyen HT; Geens M; Spits C
    Hum Reprod Update; 2013; 19(2):187-205. PubMed ID: 23223511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic aberrations in human pluripotent stem cells.
    Bar S; Benvenisty N
    EMBO J; 2019 Jun; 38(12):. PubMed ID: 31088843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells.
    Weissbein U; Plotnik O; Vershkov D; Benvenisty N
    PLoS Genet; 2017 Aug; 13(8):e1006979. PubMed ID: 28837588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects.
    Lamm N; Ben-David U; Golan-Lev T; Storchová Z; Benvenisty N; Kerem B
    Cell Stem Cell; 2016 Feb; 18(2):253-61. PubMed ID: 26669899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Characterization of X Chromosome Inactivation in Human Pluripotent Stem Cells.
    Bar S; Seaton LR; Weissbein U; Eldar-Geva T; Benvenisty N
    Cell Rep; 2019 Apr; 27(1):20-29.e3. PubMed ID: 30943402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions.
    Garitaonandia I; Amir H; Boscolo FS; Wambua GK; Schultheisz HL; Sabatini K; Morey R; Waltz S; Wang YC; Tran H; Leonardo TR; Nazor K; Slavin I; Lynch C; Li Y; Coleman R; Gallego Romero I; Altun G; Reynolds D; Dalton S; Parast M; Loring JF; Laurent LC
    PLoS One; 2015; 10(2):e0118307. PubMed ID: 25714340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic factors which modulate differentiation propensity in human pluripotent stem cells.
    Keller A; Dziedzicka D; Zambelli F; Markouli C; Sermon K; Spits C; Geens M
    Hum Reprod Update; 2018 Mar; 24(2):162-175. PubMed ID: 29377992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic instability, driver genes and cell selection: Projections from cancer to stem cells.
    Ben-David U
    Biochim Biophys Acta; 2015 Apr; 1849(4):427-35. PubMed ID: 25132386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.
    Rebuzzini P; Zuccotti M; Redi CA; Garagna S
    Cell Mol Life Sci; 2016 Jul; 73(13):2453-66. PubMed ID: 26961132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells.
    Kyriakides O; Halliwell JA; Andrews PW
    Adv Biochem Eng Biotechnol; 2018; 163():187-206. PubMed ID: 29071402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aneuploidy in pluripotent stem cells and implications for cancerous transformation.
    Na J; Baker D; Zhang J; Andrews PW; Barbaric I
    Protein Cell; 2014; 5(8):569-79. PubMed ID: 24899134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival.
    Zhang J; Hirst AJ; Duan F; Qiu H; Huang R; Ji Y; Bai L; Zhang F; Robinson D; Jones M; Li L; Wang P; Jiang P; Andrews PW; Barbaric I; Na J
    Stem Cell Reports; 2019 Mar; 12(3):557-571. PubMed ID: 30773485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.
    Krivec N; Ghosh MS; Spits C
    Stem Cell Reports; 2024 Jan; 19(1):11-27. PubMed ID: 38157850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Related Mutations Identified in Primed and Naive Human Pluripotent Stem Cells.
    Avior Y; Eggan K; Benvenisty N
    Cell Stem Cell; 2019 Oct; 25(4):456-461. PubMed ID: 31543368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumorigenicity of diploid and aneuploid human pluripotent stem cells.
    Blum B; Benvenisty N
    Cell Cycle; 2009 Dec; 8(23):3822-30. PubMed ID: 19887907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of hESC pedigrees identifies de novo mutations and enables determination of the timing and origin of mutational events.
    Ben-Yosef D; Boscolo FS; Amir H; Malcov M; Amit A; Laurent LC
    Cell Rep; 2013 Sep; 4(6):1288-302. PubMed ID: 24035391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Genetic Abnormalities in Human Pluripotent Stem Cells: Definition and Routine Detection in Culture Supernatant by Targeted Droplet Digital PCR.
    Assou S; Girault N; Plinet M; Bouckenheimer J; Sansac C; Combe M; Mianné J; Bourguignon C; Fieldes M; Ahmed E; Commes T; Boureux A; Lemaître JM; De Vos J
    Stem Cell Reports; 2020 Jan; 14(1):1-8. PubMed ID: 31902703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.
    Jo HY; Lee Y; Ahn H; Han HJ; Kwon A; Kim BY; Ha HY; Kim SC; Kim JH; Kim YO; Kim S; Koo SK; Park MH
    Sci Rep; 2020 Oct; 10(1):18582. PubMed ID: 33122739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Induction and Isolation of Human Primordial Germ Cell-Like Cells from Competent Human Pluripotent Stem Cells.
    Irie N; Surani MA
    Methods Mol Biol; 2017; 1463():217-226. PubMed ID: 27734359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.